Remodeling the TME in immunocompetent hosts is associated with substantial inhibition of tumor growth and metastasis, leading to improved survival of IL30-targeting immunoliposome-treated mice and strengthening the results obtained in xenograft tumor models. Here, IL27 is linked to neoplasm.